CCA
ELAN icon

Catalyst Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Catalyst Capital Advisors’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-632
Closed -$7.65K – 467
2024
Q4 		$7.65K Buy
632
+108
+21% +$1.41K ﹤0.01% 512
2024
Q3 		$7.7K Sell
524
-48
-8% -$669 ﹤0.01% 541
2024
Q2 		$8.25K Sell
572
-157
-22% -$2.51K ﹤0.01% 391
2024
Q1 		$11.9K Buy
+729
New +$11.4K ﹤0.01% 376
2023
Q4 		– Sell
-1,001
Closed -$11.3K – 387
2023
Q3 		$11.3K Buy
+1,001
New +$11.6K ﹤0.01% 390
2019
Q4 		– Sell
-712
Closed -$19K – 332
2019
Q3 		$19K Buy
712
+76
+12% +$2.28K ﹤0.01% 299
2019
Q2 		$22K Buy
636
+70
+12% +$2.27K ﹤0.01% 260
2019
Q1 		$18K Buy
566
+105
+23% +$3.23K ﹤0.01% 272
2018
Q4 		$15K Buy
461
+283
+159% +$9.27K ﹤0.01% 290
2018
Q3 		$6K Buy
+178
New +$6.26K ﹤0.01% 382

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Catalyst Capital Advisors's ELAN Position: Q1 2025 in Review

Catalyst Capital Advisors sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 632 shares — an estimated $7.65K sold.

Catalyst Capital Advisors first reported a position in ELAN in Q3 2018 and held it in 10 quarters. The position peaked at $22K in Q2 2019. 365 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

  • Catalyst Capital Advisors reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
  • Catalyst Capital Advisors sold 632 Elanco Animal Health shares in Q1 2025, an estimated $7.65K.
  • Catalyst Capital Advisors first reported a position in Elanco Animal Health in Q3 2018 and held it in 10 quarters.
  • Catalyst Capital Advisors's Elanco Animal Health position peaked at $22K in Q2 2019.
  • 365 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Catalyst Capital Advisors's 13F filing for Q1 2025, filed 29 Apr 2025.